Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis.
Luque Paz D, Gagelmann N, Benajiba L, Riou J, Salit RB, Orvain C, Schroeder T, Bories C, Gurnari C, Badbaran A, Boyer-Perrard F, Pagliuca S, Rautenberg C, Tavitian S, Panagiota V, Ianotto JC, Thol FR, Cayssials E, Heuser M, Rubio MT, Cassinat B, Daltro de Oliveira R, Sauter CS, Maciejewski JP, Reinhardt HC, Scott BL, Ugo V, Kröger N, Kiladjian JJ, Robin M.
Luque Paz D, et al. Among authors: reinhardt hc.
Blood Adv. 2024 Nov 19:bloodadvances.2024014368. doi: 10.1182/bloodadvances.2024014368. Online ahead of print.
Blood Adv. 2024.
PMID: 39561372